Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Contamination Control in 2026: Annex 1 Compliance, GMP Risks, and Inspection Findings

Modern sterile manufacturing relies on integrated Sterility Assurance systems aligned with Annex 1 expectations. By combining Environmental Monitoring, Aseptic Processing, and Quality Risk Management, pharmaceutical companies reduce Cleanroom Contamination risks, prevent Cross Contamination, and strengthen GMP inspection readiness.
  • Blog, Computerized System Validation
Pharmaceutical cleanroom visual showing Sterility Assurance workflows, Environmental Monitoring systems, Aseptic Processing operations, and Quality Risk Management framework supporting Annex 1 compliance and reducing Cleanroom Contamination and Cross Contamination risks.

Area Qualification In Pharma In 2026: HVAC Qualification, Cleanroom Control, and GMP Compliance Systems

Area qualification helps pharmaceutical manufacturers maintain cleanroom performance, HVAC effectiveness, and environmental control throughout the facility lifecycle. This guide explains qualification requirements, inspection risks, contamination control strategies, and ongoing activities that support GMP compliance and inspection readiness.
  • Blog, Validation and Qualification
GMP facility qualification with cleanroom classification, HVAC validation, environmental monitoring systems, and controlled manufacturing environments.